These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11044894)

  • 1. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
    Callahan BT; Yuan J; Ricaurte GA
    Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
    McCann UD; Yuan J; Ricaurte GA
    Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the perifornical hypothalamic monoamine neurotransmitter systems in anorectic effects of endotoxin.
    Adamson TW; Corll C; Svec F; Porter J
    Neuroendocrinology; 2010; 91(1):48-55. PubMed ID: 19940463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of phentermine plus fenfluramine: neurochemical and neurotoxic effects.
    Halladay AK; Fisher H; Wagner GC
    Neurotoxicology; 1998 Apr; 19(2):177-83. PubMed ID: 9553954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.
    Wellman PJ; Jones SL; Miller DK
    Pharmacol Biochem Behav; 2003 Apr; 75(1):103-14. PubMed ID: 12759118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?
    Roth JD; Rowland NE
    Eur J Pharmacol; 1999 Jun; 373(2-3):127-34. PubMed ID: 10414430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
    Garattini S; Bizzi A; Caccia S; Mennini T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenfluramine's appetite suppression and serotonin neurotoxicity are separable.
    McCann UD; Yuan J; Ricaurte GA
    Eur J Pharmacol; 1995 Sep; 283(1-3):R5-7. PubMed ID: 7498296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthetic considerations for the new antiobesity medications.
    Jeffers LA
    AANA J; 1996 Dec; 64(6):541-4. PubMed ID: 9204789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.
    Tao R; Fray A; Aspley S; Brammer R; Heal D; Auerbach S
    Eur J Pharmacol; 2002 Jun; 445(1-2):69-81. PubMed ID: 12065196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phentermine and phenformin on biomarkers of aging in rats.
    Anisimov VN; Ukraintseva SV; Anikin IV; Popovich IG; Zabezhinski MA; Bertsein LM; Arutjunyan AV; Ingram DK; Lane MA; Roth GS
    Gerontology; 2005; 51(1):19-28. PubMed ID: 15591752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is phentermine an inhibitor of monoamine oxidase? A critical appraisal.
    Rothman RB
    Synapse; 1999 May; 32(2):141-5. PubMed ID: 10231134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields.
    Lew R; Weisenberg B; Vosmer G; Seiden LS
    Synapse; 1997 May; 26(1):36-45. PubMed ID: 9097403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis.
    Alexander M; Rothman RB; Baumann MH; Endres CJ; Brasić JR; Wong DF
    Synapse; 2005 May; 56(2):94-9. PubMed ID: 15729739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan.
    Halladay AK; Wagner GC; Sekowski A; Rothman RB; Baumann MH; Fisher H
    Synapse; 2006 Apr; 59(5):277-89. PubMed ID: 16416445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drug.
    McCann UD; Yuan J; Hatzidimitriou G; Ricaurte GA
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1487-98. PubMed ID: 9190887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interactions between fenfluramine and phentermine.
    Wellman PJ; Maher TJ
    Int J Obes Relat Metab Disord; 1999 Jul; 23(7):723-32. PubMed ID: 10454106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice.
    Arch JR
    Am J Clin Nutr; 1981 Dec; 34(12):2763-9. PubMed ID: 7315777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fenfluramine/phentermine combination for weight loss.
    Garrett SD; Cupp MJ
    Nurse Pract; 1997 Aug; 22(8):166, 168, 170. PubMed ID: 9279853
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
    Johnson GJ; Leis LA; Dunlop PC; Weir EK
    J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.